Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
How do you approach Chronic Active AMR concurrent with changes of CNI toxicity?
Related Questions
What is your approach for patients with a history of nephrolithiasis who are being evaluated for living kidney donation?
What is your approach to prednisone use in a kidney transplant recipient with allograft failure, residual allograft function, and an ongoing dialysis requirement for more than one year?
What is your approach to managing a kidney transplant patient who develops BK viremia after treatment for rejection?
Would you recommend starting an SGLT2i in a patient with a kidney transplant and moderately increased albuminuria?
Do you recommend non-bypass bariatric surgeries over intestinal bypass procedures for kidney transplant-eligible candidates to prevent oxalate nephropathy, given the higher risk of kidney oxalate deposition with intestinal bypass?
Would you order a repeat DEXA scan 1 year later for a kidney transplant patient who had an initial DEXA scan within the first 6 months post-transplant showing osteopenia but no history of fractures, and who has been stable on glucocorticoid-free immunosuppressive therapy?
How has the introduction of lumasiran affected the need for combined liver and kidney transplantation in patients with ESKD related to primary hyperoxaluria type 1?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
Should all kidney transplant patients be started on statin therapy post operatively given their increased risk of CVD?
Is there a BMI cutoff for which you no longer recommend kidney transplantation in a patient with end stage kidney disease and obesity?
